Fmoc-Val-OH

Suppliers

Names

[ CAS No. ]:
68858-20-8

[ Name ]:
Fmoc-Val-OH

[Synonym ]:
L-Valine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-valine
N-Fmoc-Val-OH (N-Fmoc-L-valine)
FMco-Val-OH
N-FMOC-L-VAL
FMOC-L-VAL-OH
FMOC-VAL
FMOC-VAL-OH
MFCD00037124
N-((9H-Fluoren-9-ylmethoxy)carbonyl)-L-valine
FMOC-VALINE
FMOC-L-VALINE
N-Fmoc-L-valine
FMOC-L-VAL
N-FMOC-VAL-OH
Fmoc-Valine-OH
EINECS 272-515-0

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
551.8±33.0 °C at 760 mmHg

[ Melting Point ]:
143-147ºC

[ Molecular Formula ]:
C20H21NO4

[ Molecular Weight ]:
339.385

[ Flash Point ]:
287.5±25.4 °C

[ Exact Mass ]:
339.147064

[ PSA ]:
79.12000

[ LogP ]:
4.42

[ Vapour Pressure ]:
0.0±1.6 mmHg at 25°C

[ Index of Refraction ]:
1.590

[ Storage condition ]:
2~8°C

MSDS

Click to get detail MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xi:Irritant

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S22-S26-S36/37/39

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ HS Code ]:
2924299090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • N-(9-fluorenylmethoxycarbonyl)valine 1,1-dimethylallyl ester
  • Fmoc-Val-OPfp
  • L-Valine
  • Fmoc-Osu
  • 9-Fluorenylmethyl chloroformate
  • 3-(9-Fluorenylmethoxycarbonyl)-benzothiazoline-2-thione
  • 9H-Fluoren-9-ylmethyl pentafluorophenyl carbonate
  • 9H-fluoren-9-ylmethyl 2,5-dioxopyrrolidine-1-carboxylate
  • L-Valine hydrochloride

DownStream

  • Dansyl-Gly-Cys-Val-Leu-Ser-OH
  • Amyloid β-Protein (36-38)
  • Fmoc-L-Val-CHN2
  • L-Valine
  • 9-Methylene-9H-fluorene
  • (2R,5S)-1-Benzyl-5-isopropyl-2-methylpiperazine
  • Fmoc-Val-OPfp
  • Val-Tyr
  • Thymopentin
  • Thymopoietin II (33-36)

Customs

[ HS Code ]: 2924299090

[ Summary ]:
2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Articles

Aspartate-modified doxorubicin on its N-terminal increases drug accumulation in LAT1-overexpressing tumors.

Cancer Sci. 106 , 747-56, (2015)

L-type amino acid transporter 1 (LAT1), overexpressed on the membrane of various tumor cells, is a potential target for tumor-targeting therapy. This study aimed to develop a LAT1-mediated chemotherap...

Cell-penetrating apoptotic peptide/p53 DNA nanocomplex as adjuvant therapy for drug-resistant breast cancer.

Mol. Pharm. 11(10) , 3352-60, (2014)

Drug resistance becomes a formidable challenge against effective cancer therapy. Defective apoptosis in cancer cells is a key factor responsible for chemoresistance or radioresistance. Promoting apopt...

Design and synthesis of newN-(fluorenyl-9-methoxycarbonyl) (Fmoc)-dipeptides as anti-inflammatory agents

Eur. J. Med. Chem. 44 , 1933-40, (2009)

Twenty-four new dipeptide analogs ( 1– 24) of aurantiamide acetate were designed, synthesized, and assayed for effects on superoxide anion generation and elastase release by human neutrophils in respo...


More Articles

Related Compounds

  • Fmoc-VAL-OH
  • Fmoc-Val-OH
  • Fmoc-Val-OH-d8
  • Fmoc-Val-OH-15N
  • Fmoc-Val-OH-1-13C
  • Boc-Thr(Fmoc-Val)-OH